Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
作者： Matthew A.C. Zapf , Anai N. Kothari , Cynthia E. Weber , Matthew L. Arffa , Phillip Y. Wai
DOI: 10.1016/J.SURG.2015.06.011
关键词:
摘要: … Although EGCG treatment resulted in decreased migration in HepG2 and MHCC-97H cells, we did not demonstrate that the decreases in migration were due to lesser levels of OPN. …
sci-hub.se 参考文章(29)
H-H. Sherry Chow, Iman A. Hakim, Donna R. Vining, James A. Crowell, James Ranger-Moore, Wade M. Chew, Catherine A. Celaya, Steven R. Rodney, Yukihiko Hara, David S. Alberts, Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals Clinical Cancer Research. ,vol. 11, pp. 4627- 4633 ,(2005) , 10.1158/1078-0432.CCR-04-2549
Chyi‐Ying A. Chen, Nader Ezzeddine, Ann‐Bin Shyu, Messenger RNA half-life measurements in mammalian cells. Methods in Enzymology. ,vol. 448, pp. 335- 357 ,(2008) , 10.1016/S0076-6879(08)02617-7
Mohamed M. Darweish, Ahmed Abbas, Mohamed A. Ebrahim, Mohammed M.H. Al-Gayyar, Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. Journal of Pharmacy and Pharmacology. ,vol. 66, pp. 1032- 1045 ,(2014) , 10.1111/JPHP.12229
Daisuke Umeda, Satomi Yano, Koji Yamada, Hirofumi Tachibana, Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor Journal of Biological Chemistry. ,vol. 283, pp. 3050- 3058 ,(2008) , 10.1074/JBC.M707892200
Jinping Zhang, Hongtao Guo, Zhiyong Mi, Chengjiang Gao, Syamal Bhattacharya, Jiansheng Li, Paul C. Kuo, EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Experimental Cell Research. ,vol. 315, pp. 304- 312 ,(2009) , 10.1016/J.YEXCR.2008.10.042
Chuang Zhou, Hai-Jun Zhou, Xiao-Fei Zhang, Li-Li Lou, Qing-Hai Ye, Yan Zheng, Ji Wang, Hai-Tao Zhu, Qiong-Zhu Dong, Hu-Liang Jia, Wen-Wei Zhu, Lei Guo, Yue Zhao, Dong-Mei Gao, Lun-Xiu Qin, Postoperative Serum Osteopontin Level is a Novel Monitor for Treatment Response and Tumor Recurrence after Resection of Hepatitis B–related Hepatocellular Carcinoma Annals of Surgical Oncology. ,vol. 20, pp. 929- 937 ,(2013) , 10.1245/S10434-012-2749-9
Syamal D. Bhattacharya, Zhiyong Mi, Victoria M. Kim, Hongtao Guo, Lindsay J. Talbot, Paul C. Kuo, Osteopontin Regulates Epithelial Mesenchymal Transition-Associated Growth of Hepatocellular Cancer in a Mouse Xenograft Model Annals of Surgery. ,vol. 255, pp. 319- 325 ,(2012) , 10.1097/SLA.0B013E31823E3A1C
U Ullmann, J Haller, JP Decourt, N Girault, J Girault, AS Richard-Caudron, B Pineau, P Weber, A single ascending dose study of epigallocatechin gallate in healthy volunteers. Journal of International Medical Research. ,vol. 31, pp. 88- 101 ,(2003) , 10.1177/147323000303100205
Yoji Takami, Michael B. Russell, Chengjiang Gao, Zhiyong Mi, Hongtao Guo, Christopher R. Mantyh, Paul C. Kuo, Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells Surgery. ,vol. 142, pp. 163- 169 ,(2007) , 10.1016/J.SURG.2007.02.015
Karin B. Michels, Karin B. Michels, Fei Xue, Adeyemi A. Ogunleye, Green tea consumption and breast cancer risk or recurrence: a meta-analysis Breast Cancer Research and Treatment. ,vol. 119, pp. 477- 484 ,(2010) , 10.1007/S10549-009-0415-0